NDC 0597-0024

Combivent Respimat

Ipratropium Bromide And Albuterol

Combivent Respimat is a Respiratory (inhalation) Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals Inc.. The primary component is Ipratropium Bromide; Albuterol Sulfate.

Product ID0597-0024_27fcf69c-4fb1-cc67-36d0-865e3c741199
NDC0597-0024
Product TypeHuman Prescription Drug
Proprietary NameCombivent Respimat
Generic NameIpratropium Bromide And Albuterol
Dosage FormSpray, Metered
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2012-07-01
Marketing CategoryNDA / NDA
Application NumberNDA021747
Labeler NameBoehringer Ingelheim Pharmaceuticals Inc.
Substance NameIPRATROPIUM BROMIDE; ALBUTEROL SULFATE
Active Ingredient Strength20 ug/1; ug/1
Pharm ClassesAnticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0597-0024-02

1 CARTRIDGE in 1 CARTON (0597-0024-02) > 120 SPRAY, METERED in 1 CARTRIDGE
Marketing Start Date2012-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0597-0024-58 [00597002458]

Combivent Respimat SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021747
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-11-03
Marketing End Date2016-06-23

NDC 0597-0024-59 [00597002459]

Combivent Respimat SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021747
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-07-01
Marketing End Date2018-02-28

NDC 0597-0024-02 [00597002402]

Combivent Respimat SPRAY, METERED
Marketing CategoryNDA
Application NumberNDA021747
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2012-07-01

Drug Details

Active Ingredients

IngredientStrength
IPRATROPIUM BROMIDE20 ug/1

OpenFDA Data

SPL SET ID:9832312e-0310-4ab6-8501-afa976fc7eb2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1190220
  • 1190225
  • Pharmacological Class

    • Anticholinergic [EPC]
    • Cholinergic Antagonists [MoA]
    • Adrenergic beta2-Agonists [MoA]
    • beta2-Adrenergic Agonist [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.